GlassScriptPrepare for your visit
Joomee Shim
Hematology & Oncology · Los Angeles, CA · NPI 1942526934
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,476.18
in general payments reported to CMS, 2019-2025 · $629 in 2025
The $629 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Who reported paying
General payments only, top 6 by amount.
- Pfizer INC. $723.30
- Amgen INC. $482.54
- Incyte Corporation $419.61
- Novartis Pharmaceuticals Corporation $379.63
- Takeda Pharmaceuticals U.S.A., INC. $341.58
- Abbvie INC. $297.99
Drugs and devices associated with these payments
Enhertu Elahere Tibsovo Cabometyx Empaveli Korlym Kisqali Nubeqa Mi Cancer Seek Venclexta Xtandi Orgovyx
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Joomee Shim listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/2793599/joomee-shim